Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS · BSE: 544222 · Pharmaceuticals & Biotechnology · 35 announcements

Share price: ₹821.50
Market cap: ₹12,930 Cr
Revenue (annual): ₹4,359 Cr
Net profit (annual): ₹255.2 Cr
P/E (TTM): 44.3×Sector 47.4×
Promoter holding: 75.26%+0.00% QoQ
FII holding: 1.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 7 Earnings Call 5 Legal & Regulatory 4 Financial Results 4 Adverse Business Impact 3 Results Update 2 Management Change 2 Board Meeting Date 2 Merger & Restructuring 1 Fund Raise 1 Credit Rating 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 May 2026 17:50 IST NSE

Board Meeting Outcome

Akums Drugs & Pharmaceuticals Board Meeting Outcome

Akums Drugs and Pharmaceuticals re-appointed M/s. Balwinder & Associates as Cost Auditors for 12 months. The decision strengthens the company's regulatory compliance and cost oversight.

Execution: 12 months

Read the filing ↗